CrushSCI.com
227.8平均天数
211中位天数
54最短天数
567最长天数
9872025发文量

Paper Review Records

全部论文审稿周期

25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

92 天

Frequency and Timing of Depression and Anxiety Diagnoses Following Cancer Diagnosis: A Multi‐Center Cohort Study

作者
Suraj Manohar Rajan; Vivian Tran; Aaron‐john Lee; Carol Y. Ochoa‐Dominguez; Joshua Demb; Melody K. Schiaffino; Edmund Qiao; Tyler Seibert; James Murphy; Brent Rose; Matthew P. Banegas展开收起
作者单位
1. UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science San Diego California USA; 2. Center for Health Equity Education and Research University of California San Diego California USA; 3. Department of Radiation Medicine & Applied Sciences University of California San Diego California USA; 4. San Diego State University San Diego California USA展开收起
PDF源文件 DOI 网页
175 天

Perspectives on Education From Gastrointestinal ( GI ) Cancer Patients in the Deep South: Qualitative Analysis

作者
Gianina C. Hernandez‐Marquez; Nataliya V. Ivankova; Nathan C. English; Wendelyn M. Oslock; Alizeh Abbas; Alfonsus Adrian H. Harsono; Bayley A. Jones; Ivan I. Herbey; Gurudatta Naik; Yu‐Mei M. Schoenberger‐Godwin; Daniel I. Chu; Maria Pisu展开收起
作者单位
1. Department of Surgery University of Alabama at Birmingham Birmingham Alabama USA; 2. School of Health Professions University of Alabama at Birmingham Birmingham Alabama USA; 3. Department of General Surgery University of Cape Town Cape Town South Africa; 4. Department of General Surgery University of Texas Southwestern Dallas Texas USA; 5. Division of Preventive Medicine and O'Neal Comprehensive Cancer Center University of Alabama at Birmingham Birmingham Alabama USA展开收起
PDF源文件 DOI 网页
270 天

Current Advances of Molecular Biomarkers and Liquid Biopsies Techniques in Ovarian Cancer

作者
Jingxia Zhang; Weiyan Shan; Jie Yu; Huan Shi; Qiaoping Xu; Hongkai Shang展开收起
作者单位
1. The Fourth Clinical Medical College of Zhejiang Chinese Medical University Hangzhou China; 2. Department of Clinical Pharmacology Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Cancer Center, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine Hangzhou China; 3. Department of Gynecology Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Zhejiang Hangzhou China展开收起
PDF源文件 DOI 网页
205 天

A Novel Aerogel Delivery System Reduces Drug Resistance for Non‐Small Cell Lung Cancer Combination Therapy

作者
Dingwei Diao; Yu Tong; Jianxue Zhai; Shijie Mai; Xiguang Liu; Xuguang Rao; Kaican Cai展开收起
作者单位
1. The Department of Thoracic Surgery Nanfang Hospital, Southern Medical University Guangzhou Guangdong China展开收起
PDF源文件 DOI 网页
263 天

Feasibility of Integrating a Standardized Psychosocial Follow‐Up After Childhood Cancer—An Interim Analysis of the LE ‐Na Study

作者
Madelaine Sleimann; Magdalena Balcerek; Gabriele Calaminus; Martina B. Schaefer; Rainer John; Judith Lohse; Sonja Schuster; Teresa Halbsguth; Alexander Puzik; Franziska Wolters; Jörg Faber; Irene von Luettichau; Sophia Hömberg; Sebastian Michaelis; Melanie Kaiser; Desiree Grabow; Inke König; Anke Neumann; Ann‐Kristin Kock‐Schoppenhauer; Celina Arendt; Thorsten Langer; Katja Baust; Judith Gebauer展开收起
作者单位
1. Department of Pediatrics University Hospital Schleswig‐Holstein Lübeck Germany; 2. Department of Pediatric Oncology and Hematology Charité–Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany; 3. Department of Oncology, Hepatology and Pneumology University Hospital Leipzig and University Cancer Center Leipzig Leipzig Germany; 4. Clinic for Pediatric Hematology and Oncology, Center for Pediatric and Adolescent Medicine University Hospital Bonn Bonn Germany; 5. Clinic and Polyclinic for Pediatrics and Adolescent Medicine, Department of Pediatric Hematology and Oncology University Hospital Carl Gustav Carus, Technische Universität Dresden Dresden Germany; 6. Department of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine University Hospital Erlangen, Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Erlangen Germany; 7. Department of Medicine II, Hematology and Oncology, University Cancer Center (UCT) Frankfurt University Hospital Frankfurt, Goethe University Frankfurt Frankfurt am Main Germany; 8. Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, Medical Center, Faculty of Medicine University of Freiburg Freiburg Germany; 9. Department of Hematology and Oncology With Section Pneumology, Hubertus Wald Tumor Center–University Cancer Center Hamburg University Medical Center Hamburg‐Eppendorf (UKE) Hamburg Germany; 10. Department of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine University Medical Center Mainz Mainz Germany; 11. Center for Pediatrics and Adolescent Medicine, a Collaboration Between Munich Clinic and TUM University Hospital Rechts der Isar, TUM School of Medicine and Health Munich Germany; 12. Department of Pediatric Hematology and Oncology Asklepios Children's Hospital Sankt Augustin Sankt Augustin Germany; 13. Department I of Pediatric Hematology and Oncology University Children's Hospital Tübingen Tübingen Germany; 14. Department of Epidemiology of Childhood Cancer (EpiKiK)/German Childhood Cancer Registry (DKKR), Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI) University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany; 15. Institute of Medical Biometry and Statistics (IMBS), University of Luebeck, University Hospital Schleswig‐Holstein Lübeck Germany; 16. Section for Clinical Research IT (SKFIT) Institute of Medical Biometry and Statistics (IMBS), University of Luebeck and University Hospital Schleswig‐Holstein Lübeck Germany; 17. Department of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine University Hospital Schleswig‐Holstein Lübeck Germany; 18. Department of Hematology and Oncology University Hospital Schleswig‐Holstein Lübeck Germany展开收起
PDF源文件 DOI 网页
326 天

CRISPR Screen Reveals Pathways and Factors Driving Tyrosine Kinase Inhibitor Resistance in Hepatocellular Carcinoma

作者
Si‐Yu Chen; Li‐Hua Yang; Zi‐Qian Liang; Jian‐Di Li; Shi‐de Li; Yu‐Long Deng; Guo‐Qiang Chen; Jing‐Wen Ling; Sheng‐Sheng Zhou; Gang Chen; Rong‐Quan He展开收起
作者单位
1. Department of Pathology The First Affiliated Hospital of Guangxi Medical University Nanning China; 2. Department of Medical Oncology The First Affiliated Hospital of Guangxi Medical University Nanning China; 3. Department of Information Management and Information System, School of Information and Management Guangxi Medical University Nanning China; 4. Department of Medical Information Engineering, School of Information and Management Guangxi Medical University Nanning China展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。